These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 22191083)

  • 1. Agomelatine: a novel antidepressant.
    Sansone RA; Sansone LA
    Innov Clin Neurosci; 2011 Nov; 8(11):10-4. PubMed ID: 22191083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agomelatine and its therapeutic potential in the depressed patient.
    Kennedy SH; Eisfeld BS
    Neuropsychiatr Dis Treat; 2007 Aug; 3(4):423-8. PubMed ID: 19300571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.
    Howland RH
    Neuropsychiatr Dis Treat; 2009; 5():563-76. PubMed ID: 19966905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation.
    Fornaro M; Prestia D; Colicchio S; Perugi G
    Curr Neuropharmacol; 2010 Sep; 8(3):287-304. PubMed ID: 21358978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agomelatine: The evidence for its place in the treatment of depression.
    Eser D; Baghai TC; Möller HJ
    Core Evid; 2010 Jun; 4():171-9. PubMed ID: 20694073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?
    Fornaro M; Bandini F; Cestari L; Cordano C; Ogliastro C; Albano C; De Berardis D; Martino M; Escelsior A; Rocchi G; Fornaro P; De Pasquale C
    Neuropsychiatr Dis Treat; 2014; 10():907-14. PubMed ID: 24899809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice.
    Nadar JS; Kale PP; Kadu PK; Prabhavalkar K; Dhangar R
    Neurol Res Int; 2018; 2018():9828639. PubMed ID: 30510800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of agomelatine in the treatment of depression.
    Plesničar BK
    Patient Prefer Adherence; 2014; 8():603-12. PubMed ID: 24833894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of agomelatine and its potential in the treatment of generalized anxiety disorder.
    Levitan MN; Papelbaum M; Nardi AE
    Neuropsychiatr Dis Treat; 2015; 11():1149-55. PubMed ID: 25999720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emergence of new antidepressants for clinical use: Agomelatine paradox versus other novel agents.
    Fasipe OJ
    IBRO Rep; 2019 Jun; 6():95-110. PubMed ID: 31211282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parallel Changes in Mood and Melatonin Rhythm Following an Adjunctive Multimodal Chronobiological Intervention With Agomelatine in People With Depression: A Proof of Concept Open Label Study.
    Robillard R; Carpenter JS; Feilds KL; Hermens DF; White D; Naismith SL; Bartlett D; Whitwell B; Southan J; Scott EM; Hickie IB
    Front Psychiatry; 2018; 9():624. PubMed ID: 30618853
    [No Abstract]   [Full Text] [Related]  

  • 12. Agomelatine strongly interacts with zwitterionic DPPC and charged DPPG membranes.
    Ergun S; Demir P; Uzbay T; Severcan F
    Biochim Biophys Acta; 2014 Nov; 1838(11):2798-806. PubMed ID: 25091390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agomelatine in unipolar depression in clinical practice: a retrospective chart review.
    Langan J; Shajahan P; Martin D; Carleton R
    Ther Adv Psychopharmacol; 2011 Dec; 1(6):175-80. PubMed ID: 23983944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agomelatine: A novel melatonergic antidepressant.
    Manikandan S
    J Pharmacol Pharmacother; 2010 Jul; 1(2):122-3. PubMed ID: 21350627
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute Hepatitis Due to Agomelatine Use in Elderly Women with Depression: Case Series.
    Chang CC; Chen YJ; Chen YA; Liao YC
    Clin Psychopharmacol Neurosci; 2021 Nov; 19(4):789-792. PubMed ID: 34690134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agomelatine: A Potential Multitarget Compound for Neurodevelopmental Disorders.
    Savino R; Polito AN; Marsala G; Ventriglio A; Di Salvatore M; De Stefano MI; Valenzano A; Marinaccio L; Bellomo A; Cibelli G; Monda M; Monda V; Messina A; Polito R; Carotenuto M; Messina G
    Brain Sci; 2023 Apr; 13(5):. PubMed ID: 37239206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Acupuncture in the Management of Insomnia as a Major or Residual Symptom Among Patients With Active or Previous Depression: A Systematic Review and Meta-Analysis.
    Zhao FY; Kennedy GA; Spencer SJ; Conduit R; Zhang WJ; Fu QQ; Zheng Z
    Front Psychiatry; 2022; 13():863134. PubMed ID: 35492706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emotional Blunting in Patients With Major Depressive Disorder: A Brief Non-systematic Review of Current Research.
    Ma H; Cai M; Wang H
    Front Psychiatry; 2021; 12():792960. PubMed ID: 34970173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aryl Transfer Strategies Mediated by Photoinduced Electron Transfer.
    Allen AR; Noten EA; Stephenson CRJ
    Chem Rev; 2022 Jan; 122(2):2695-2751. PubMed ID: 34672526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medications for sleep disturbance in children and adolescents with depression: a survey of Canadian child and adolescent psychiatrists.
    Boafo A; Greenham S; Sullivan M; Bazaid K; Suntharalingam S; Silbernagel L; Magner K; Robillard R
    Child Adolesc Psychiatry Ment Health; 2020; 14():10. PubMed ID: 32175006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.